| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/31/2026 | ±2.0% | -6.0% | under-priced |
| 05/01/2026 | ±1.5% | +1.4% | over-priced |
| 10/31/2025 | ±1.6% | -2.7% | under-priced |
| 08/01/2025 | ±1.4% | -0.2% | over-priced |
| 05/01/2025 | ±1.7% | -1.1% | over-priced |
| 10/31/2024 | ±1.0% | -3.6% | under-priced |
| 08/02/2024 | ±1.7% | +0.1% | over-priced |
| 05/02/2024 | ±1.4% | -5.2% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $4.15 | $9.3B | $2.0B |
| Q1 FY2026 | $3.98 | $8.8B | $1.9B |
| Q4 FY2025 | $3.27 | $8.8B | $1.6B |
| Q3 FY2025 | $4.09 | $8.6B | $2.0B |
Linde plc Ordinary Share (LIN) reports in 72 days, with the next report estimated for 11/23/2026. Across the last 8 reports, options priced an average ±1.5% earnings move while the stock actually moved 2.5% on average — the market has been roughly fair on LIN's earnings risk. Fundamentals into the print: EPS up 11.3% year-over-year, revenue up 9.3%. QuantLogix's live 5-factor engine currently reads LIN as a neutral at 49/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →